SEC Comment Letter 0000000000-25-006567 to 180 Life Sciences Corp. (ATNF, ATNFW) (CIK 0001690080) (ETHZ)
180 Life Sciences Corp. (ATNF, ATNFW) (CIK 0001690080)
Date: June 24, 2025 · CIK: 0001690080 · Accession: 0000000000-25-006567
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288194
Letter
Re: 180 Life Sciences Corp. Registration Statement on Form S-3 Filed June 20, 2025 File No. 333-288194 Dear Blair Jordan:
June 24, 2025
Blair Jordan Chief Executive Officer 180 Life Sciences Corp. 3000 El Camino Real, Bldg. 4, Suite 200 Palo Alto, CA 94306
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: David M. Loev
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 24, 2025 Blair Jordan Chief Executive Officer 180 Life Sciences Corp. 3000 El Camino Real, Bldg. 4, Suite 200 Palo Alto, CA 94306 Re: 180 Life Sciences Corp. Registration Statement on Form S-3 Filed June 20, 2025 File No. 333-288194 Dear Blair Jordan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David M. Loev </TEXT> </DOCUMENT>